Abstract:Objective To compare the efficacy and toxicity of vinorelbine plus cisplatin(NP) and paclita-xel plus cisplatin(TP) combinations in the treatment of advanced non-small-cell lung cancer(NSCLC) .Methods From December 1997 to April 2002, a total of 59 patients with advanced NSCLC were randomized to receive vinorelbine 25 mg/m2 on days 1,8 by twenty-minute infusion and cisplatin 45 mg/m2 on day 1 (group NP) , or paclita-xel 135 mg/m2 by 3-hour infusion and cisplatin 80 mg/m2 on day 1(group TP). Both regimens were repeated every 3 weeks. Results A total of 59 patients (30 patients in group TP, 29 patients in group TP) were enrolled. All characteristics were well matched between the two groups. In total, 188 cycles of NP and 93 cycles of TP were given. The median duration of response was 5.5 months for group NP and 4.5 months for group TP.The overall response rate for group NP was 46.7% , with 6.6% complete response(CR) ,40.0% partial response(PR) ,40.0% stable disease(SD) and 13. 3% progression of disease(PD), and in group TP, the overall response rate was 44. 8% (3.4% CR,41.4% PR,37.9% SD,and 17.2% PD)(P0.75).The response rate was higher in grade Ⅲb cases than in grade Ⅳ cases(77.8% vs 33.3% in group NP,P = 0.0288,and 85.7% vs 31.8% in group TP, P = 0.0176),higher in previously untreated cases than in treated cases(72.7% vs 31.6% in group NP, P = 0.0308,and 75.0% vs 33.3% in group TP, P = 0.0480).The incidence of neutropenia and thrombocytopenia were 66.7% and 51.7% in group NP,and 33.3% and 31.0% in group TP,respectively.Phlebitis(63.3% vs 3.4%)and nausea/vomiting(55.3% vs 41.4%)were more severe in group NP.By contrast,alopecia(93.1% vs 23.3%)and peripheral neurotoxicity/myalgia(72.4% vs 36.7%)were more frequent in group TP.The frequency and severity of other toxic reactions were comparable between the two groups. No WHO grade Ⅳ toxicity occurred. Conclusion Both NP and TP combined chemotherapy produce similar efficacy and are well tolerated in patients with advanced non-small-cell lung cancer.

Vinorelbine plus cisplatin in the treatment of 48 cases with advanced non-small-cell lung cancer

[Vinorelbine Plus Cisplatin in the Treatment of Advanced Non-Small Cell Lung Cancer Previously Treated with Taxane-Based Chemotherapy].

Vinorelbine based combination chemotherapy in advanced non-small cell lung cancer

Comparison of Cisplatin-Mitomycin-vinorelbine Versus Cisplatin-Mitomycin-vindesine Regimen for Treatment of Advanced Non-Small Cell Lung Cancer: a Report of 83 Patients

Compare and Evaluate Two Combination Regimens of Vinorelbine Plus Gemcitabine and Cisplatin Pins Vinorelbine for Treatment of Patients with Advanced Non-Small-cell Lung Cancer

Vinorelbine Plus Oxaliplatin in the Treatment of 26 Cases of Advanced Non-Small Cell Lung Cancer

Clinical efficacy of navelbine plus cisplatin in the treatment of advanced non - small cell lung cancer

Clinical Study of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Treatment of Patients with Advanced Non-Small-cell Lung Cancer

Comparison of Short-term Efficacy between the NP and GP Regimens in the Treatment of Advanced Non-small-cell Lung Canaer

Clinical Study of Vinorelbine Combined with Cisplatin in the Treatment of Advanced Esophageal Cancer

Chemotherapy Based on Regimes of Gemcitabine Plus Cisplatin or Vinorelbine Plus Cisplatin in Patients with Advanced NSCLC

Three Dimensional-conformal Radiotherapy Combined Concurrent Chemotherapy with Vinorelbine and Cisplatin for Stage Ⅲ Non-small Cell Lung Cancer

Comparasion on Two Combination Regimens of Nedaplatin Plus Gemcitabine and Cisplatin Plus Gemcitabine for Treatment of Patients with Advanced Non Small-cell Lung Cancer

Post-operative treatment with cisplatin and vinorelbine in Chinese patients with non-small cell lung cancer: a clinical prospective analysis of 451 patients.

[Effects of vinorelbine plus cisplatin as second-line neoadjuvant chemotherapy regimen in the treatment of breast cancer].

CLINICAL EFFICACY OF VINORELBINE PLUS CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER

The Role of Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small-cell Lung Cancer

Three Cisplatin-Based Regimens in Treatment of Advanced Non-Small Cell Lung Cancer

Observation on Efficacy of NP Regimen Combined with Qingrejiedu Decoction in Treatment of Non-Small Cell Lung Cancer: a Report of 72 Cases

Continuous Intravenous Vinorelbine Infusion Plus Cisplatin in the Treatment of Advanced Non-small Cell Lung Cancer

First-line Chemotherapy of Docetaxel/Cisplatin for Advanced Non-small Cell Lung Cancer